Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis
Parisa Bonyadi, Narjes Tehrani Saleh, Mohadeseh Dehghani, et al.
Microbial Pathogenesis (2022) Vol. 165, pp. 105461-105461
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Advances in Nanotechnology for Biofilm Inhibition
Lokender Kumar, Monish Bisen, Kusum Harjai, et al.
ACS Omega (2023) Vol. 8, Iss. 24, pp. 21391-21409
Open Access | Times Cited: 69
Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future
Evanthia Perikleous, Despoina Gkentzi, Aris Bertzouanis, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 217-217
Open Access | Times Cited: 30
Uncovering the NAFLD burden in people living with HIV from high‐ and middle‐income nations: a meta‐analysis with a data gap from Subsaharan Africa
Ramiro Manzano-Núñez, Jesús Rivera‐Esteban, Jordi Navarro, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 18
Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum
Samuel L. Neff, Georgia Doing, Taylor Reiter, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 7
Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis
Negar Narimisa, Abbasali Keshtkar, Leila Dadgar-Zankbar, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patients
Daan F. van den Berg, Stan J. J. Brouns
mBio (2025)
Open Access
Antimicrobial activity of new anti-Pseudomonas beta-lactam-beta-lactamase inhibitors against Pseudomonas aeruginosa respiratory isolates recovered during the study for Monitoring Antimicrobial Resistance Trends (SMART) program in France (2016–2022)
C. Zins, Hélène Pailhoriès, Rachel Chenouard, et al.
Infectious Diseases Now (2025), pp. 105056-105056
Closed Access
Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon
Maria Isabel Montoril Gouveia, Edilene do Socorro Nascimento Falcão Sarges, Herald Souza dos Reis, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
An Update of Mobile Colistin Resistance in Non-Fermentative Gram-Negative Bacilli
Piyatip Khuntayaporn, Krit Thirapanmethee, Mullika Traidej Chomnawang
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
The Impact of Antimicrobial Resistance in Cystic Fibrosis
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 4
Flowering phenophases influence the antibacterial and anti-biofilm effects of Thymus vulgaris L. essential oil
Csongor Bakó, Viktória Lilla Balázs, Erika Beáta Kerekes, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Antimicrobial Resistance, Genetic Lineages, and Biofilm Formation in Pseudomonas aeruginosa Isolated from Human Infections: An Emerging One Health Concern
Adriana Silva, Vanessa Silva, María López, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1248-1248
Open Access | Times Cited: 9
Nanoformulated Meloxicam and Rifampin: Inhibiting Quorum Sensing and Biofilm Formation in Pseudomonas Aeruginosa
Malihe Khorramdel, Fatemeh Peyravii Ghadikolaii, Seyed Isaac Hashemy, et al.
Nanomedicine (2024) Vol. 19, Iss. 7, pp. 615-632
Closed Access | Times Cited: 2
Antibiotic Resistance Patterns of Pseudomonas aeruginosa Bacterial Species Isolated from Various Clinical Samples
Qandeel Abbass Soomro, Abdul Nabi, Sarfraz Ali Tunio, et al.
Pakistan Journal of Health Sciences (2024), pp. 32-37
Closed Access | Times Cited: 2
High-Risk Pseudomonas aeruginosa Clones Harboring β-Lactamases: 2024 Update.
Verónica Roxana Flores-Vega, Santiago Partida‐Sánchez, Miguel A. Ares, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41540-e41540
Open Access | Times Cited: 2
Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
Gabriele Carullo, Giovanni Di Bonaventura, Sara Rossi, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6535-6535
Open Access | Times Cited: 5
Tetramerization is essential for the enzymatic function of the Pseudomonas aeruginosa virulence factor UDP-glucose pyrophosphorylase
Larissa Dirr, Sven Cleeves, Isabel Ramón Roth, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 1
Cystic fibrosis management in pediatric population—from clinical features to personalized therapy
Alice Azoicăi, Ancuța Lupu, Laura Mihaela Trandafir, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Genomic Comparative of Pseudomonas aeruginosa Small Colony Variant, Mucoid and Non-mucoid Phenotypes Obtained from a Patient with Cystic Fibrosis During Respiratory Exacerbations
Mila M. Almeida, Leonardo Ribeiro Bastos, Mônica de Cássia Firmida, et al.
Current Microbiology (2024) Vol. 81, Iss. 9
Closed Access | Times Cited: 1
Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage
Jagdev Singh, Stephanie Lynch, Jonathan R. Iredell, et al.
Virus Research (2024) Vol. 348, pp. 199442-199442
Open Access | Times Cited: 1
Spatiotemporal distribution of the planktonic microbiome and antibiotic resistance genes in a typical urban river contaminated by macrolide antibiotics
Chuanmao Yang, Shiwei Yan, Baihuan Zhang, et al.
Environmental Research (2024) Vol. 262, pp. 119808-119808
Closed Access | Times Cited: 1
Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance
Karl A. Glen, Iain L. Lamont
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges
Jack S. Canning, Daniel R. Laucirica, Kak‐Ming Ling, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
David de la Rosa, Guillermo Suárez-Cuartín, Rafael Golpe, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 7271-7292
Open Access | Times Cited: 6
Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development
Samuel L. Neff, Thomas H. Hampton, Katja Koeppen, et al.
mSystems (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top